コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 abnormalities in endochondral ossification (chondrodysplasias).
2 Hspg2-/- mice developed both exencephaly and chondrodysplasia.
3 Postnatal ablation of S1P results in chondrodysplasia.
4 estigate the mechanisms responsible for this chondrodysplasia.
5 eoclast populations, they do not improve the chondrodysplasia.
6 Smads 1, 5 and 8, however, results in severe chondrodysplasia.
7 lts in normally patterned limbs that display chondrodysplasia.
8 ening, epiphyseal distortion, and widespread chondrodysplasia.
9 e hematopoietic dysfunction, and metaphyseal chondrodysplasia.
10 nd future treatment of combined dwarfism and chondrodysplasia.
11 double mutants develop a severe generalized chondrodysplasia.
12 esulting Tgfbr1 (Col2) mice exhibited lethal chondrodysplasia.
13 also produces a similar phenotype of severe chondrodysplasia.
14 reating a phenotype resembling dwarfism with chondrodysplasia.
15 cy, bone marrow dysfunction, and metaphyseal chondrodysplasia.
16 as the pathogenetic basis of a novel form of chondrodysplasia.
17 seal dysplasia tarda (SEDT), a rare X-linked chondrodysplasia.
18 receptors described in Jansen's metaphyseal chondrodysplasia.
19 null fetuses die with a severe, generalized chondrodysplasia.
20 ecific collagens are responsible for several chondrodysplasias.
21 ate, since mutations in both molecules cause chondrodysplasias.
22 s the prototype and most common of the human chondrodysplasias.
23 responsible for a collection of short-limbed chondrodysplasias.
24 whose function is impaired in several human chondrodysplasias.
25 eous group of genetic disorders known as the chondrodysplasias.
26 ility that FN assembly defects contribute to chondrodysplasias.
27 ocopied defects observed in human hereditary chondrodysplasias.
28 been found in Jansen-type human metaphyseal chondrodysplasia, a disease characterized by delayed ske
29 ound in a patient with Jansens's metaphyseal chondrodysplasia, a rare form of short-limbed dwarfism a
30 ate, and in patients with Jansen metaphyseal chondrodysplasia, a rare genetic disorder caused by cons
31 factor 4 (fgf4) is strongly associated with chondrodysplasia, a short-legged phenotype that defines
32 nt observation that a third even more severe chondrodysplasia, achondrogenesis type IB, is also cause
33 hCDMP-1 is associated with a recessive human chondrodysplasia (acromesomelic chondrodysplasia, Hunter
36 last growth factor (FGF) receptors result in chondrodysplasia and craniosynostosis syndromes, highlig
41 FGF mice exhibit phenotypes characterized by chondrodysplasia and macrocephaly, which affect endochon
42 an essential node in the network of ciliary chondrodysplasia and nephronophthisis-like disease prote
45 s of retinal degeneration, kidney cysts, and chondrodysplasia and results from mutations in the ift80
47 rogeneous cartilage disorders including some chondrodysplasias and certain forms of heritable osteoar
49 ulfation, provide a unique genetic basis for chondrodysplasia, and define a function for gPAPP in the
51 elta/Delta) mice had craniofacial dysplasia, chondrodysplasia, and kyphosis, with most mice dying by
54 radiologic evidence of Jansen's metaphyseal chondrodysplasia but less severe hypercalcemia, no recep
55 keletal growth inhibition, malformation, and chondrodysplasia, but showed unimpaired mineralization i
56 he activation of sulfatases, causes a severe chondrodysplasia by augmenting fibroblast growth factor
57 The analysis of individuals with ciliary chondrodysplasias can shed light on sensitive mechanisms
58 dwarfism, is an inherited autosomal-dominant chondrodysplasia caused by a gain-of-function mutation i
60 ic dysplasia (DTD) is an incurable recessive chondrodysplasia caused by mutations in the SLC26A2 tran
61 genes in the pathogenesis of specific human chondrodysplasias caused by activating mutations in Fgfr
63 II collagen promoter induces a novel form of chondrodysplasia characterized by short-limbed dwarfism
64 erences, both male and female four-month-old chondrodysplasia (Cho/+) mice, which develop progressive
65 1A2 encoding the chains of Type I collagen), chondrodysplasias (COL2A1 encoding the chains of Type II
67 ST mutations found in individuals with these chondrodysplasias differ functionally from each other, w
70 the catalytic site, which are known to cause chondrodysplasia in humans, recapitulate defects in over
74 ort capacity of each DTDST mutation with the chondrodysplasia in which it has been identified, we fin
76 gene, encoding procollagen-II, cause various chondrodysplasias, including precocious osteoarthritis w
81 hypoplasia (CHH), also known as metaphyseal chondrodysplasia McKusick type (OMIM no. 250250), is an
82 lts demonstrate a phenotypic series of three chondrodysplasias of increasing severity caused by lesio
84 g thoracic dystrophy, an autosomal recessive chondrodysplasia, often leads to death in infancy becaus
88 The smpd3(-/-) mouse shares its dwarf and chondrodysplasia phenotype with the most common form of
91 eoarthritis together with features of a mild chondrodysplasia probably best classified as spondyloepi
92 etic mechanism behind two clinically related chondrodysplasias, PSACH and multiple epiphyseal dysplas
95 may be homologous to human X-linked dominant chondrodysplasia punctata (CDPX2) and incontinentia pigm
96 ozygous females with human X-linked dominant chondrodysplasia punctata (CDPX2, alternatively known as
101 ects in the human protein causing rhizomelic chondrodysplasia punctata (RCDP), a severe, lethal perox
103 cient ether lipid biosynthesis in rhizomelic chondrodysplasia punctata and other disorders is associa
104 including Zellweger syndrome and rhizomelic chondrodysplasia punctata are caused by genetic defects
105 phy, infantile Refsum disease and rhizomelic chondrodysplasia punctata are progressive disorders char
108 erolosis, lathosterolosis, X-linked dominant chondrodysplasia punctata type 2 (CDPX2), congenital hem
109 erolosis, desmosterolosis, X-linked dominant chondrodysplasia punctata type 2, and congenital hemidys
110 mith-Lemli-Opitz syndrome, X-linked dominant chondrodysplasia punctata, and cerebrotendinous xanthoma
111 nylketonuria, propionic acidemia, rhizomelic chondrodysplasia punctata, and the Zellweger spectrum di
112 dentified-desmosterolosis, X-linked dominant chondrodysplasia punctata, CHILD syndrome, lathosterolos
113 ping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysp
114 erved in cells from patients with rhizomelic chondrodysplasia punctata, Refsum disease, X-linked adre
119 ic differentiation of chondrocytes and cause chondrodysplasias similar to those caused by mutations i
120 ondensations, exhibited a severe generalized chondrodysplasia, similar to that in Sox5; Sox6 double-n
121 indings shed light on the cellular basis for chondrodysplasia syndromes and formation of the vertebra
124 e responsible for four recessively inherited chondrodysplasias that include diastrophic dysplasia, mu
125 been identified in a phenotypic continuum of chondrodysplasias that range widely in clinical severity
126 al characteristics resemble those of another chondrodysplasia, the much less severe diastrophic dyspl
128 as exemplified by achondroplasia and related chondrodysplasias, which are caused by constitutively ac
129 nesis type II (AO II) is a neonatally lethal chondrodysplasia whose clinical and histological charact
130 king the perlecan gene (Hspg2) have a severe chondrodysplasia with dyssegmental ossification of the s
133 e II collagen protein (Col II) and displayed chondrodysplasia with no endochondral bone formation eve